Company Profile
CEO
Mr. Bernard J. Zovighian(CEO & Director)
Sector
Healthcare
Industry
Medical Devices
Employees
16.0K
Beta
0.87
Forward P/E
25.5
52W High
$89.44
52W Low
$72.30
Profit Margin
17.4%
Operating Margin
31.2%
Return on Equity
10.5%
Revenue Growth
16.7%
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards...
Valuation
Market Cap$49.43B
P/E (TTM)45.70
P/S (TTM)7.50
EV/EBITDA22.94
Cash Flow
FCF Yield-0.2%
SBC Adj. FCF Yield-0.5%
SBC Impact215.2%
Margins & Growth
Profit Margin23.1%
Operating Margin29.0%
Revenue YoY16.7%
Earnings YoY6.3%
Balance
Cash$2.45B
Debt$598.50M
Net Cash$1.85B
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--